Breaking

Pennsylvania State Police helicopter and small plane collide and crash; no word on possible injuries ‘Fed up with a war they didn't want’: Midwestern voters air frustrations impacting the midterms Trump threatens 'tremendous economic consequences' on any country helping Iran Cavs acquiring Peyton Watson and trading Max Strus to Clippers in 4-team deal, AP source says Magicians and margarine: 10 of the funniest jokes from the Edinburgh fringe 2026 A timeline of Prince Harry and Meghan’s relationship with the royal family as they return to the UK Weatherwatch: Climate crisis fuelling steep fall in migratory bird numbers Alex Eala's US Open campaign could elevate her career to new heights UK cinemas look at banning Meta smart glasses over piracy fears Marvel’s Wolverine: Spider-Man developers turn to a more cutthroat character

NEWSREEL

The day, in 30-second reels.

--:--:--

Sports / Reel

Sports · Video brief

Braves, Strider await doc's evaluation of elbow

Spencer Strider's elbow inflammation has the Atlanta Braves on edge as they await a crucial evaluation. With his recent performance decline and past surgery history, the team faces uncertainty. Meanwhile, Drake Baldwin's promising rehab gam...

ESPN· Jun 14, 2026 · 7:31 PM · 25 views

Video won't play? Watch on YouTube →

Spencer Strider's elbow inflammation has the Atlanta Braves on edge as they await a crucial evaluation. With his recent performance decline and past surgery history, the team faces uncertainty. Meanwhile, Drake Baldwin's promising rehab game offers a glimmer of hope. How will this impact the Braves' season?

#MLB #Braves #SpencerStrider #InjuryUpdate #BaseballNews

Originally reported by ESPN. Read the full story →

More in Sports

Cavs acquiring Peyton Watson and trading Max Strus to Clippers in 4-team deal, AP source says

AP News· 3 hours ago

Alex Eala's US Open campaign could elevate her career to new heights

ESPN· 3 hours ago

Robot building and Essien: Yirenkyi’s circuitous path to Premier League

The Guardian Sport· 3 hours ago

0 Comments

No comments yet. Be the first.